Mitosis, the accurate segregation of duplicated genetic material into what will become two new daughter cells, is accompanied by extensive membrane remodelling and membrane trafficking activities. Early in mitosis, adherent cells partially detach from the substratum, round up and their surface area decreases. This likely results from an endocytic uptake of plasma membrane material. As cells enter cytokinesis they re-adhere, flatten and exhibit an associated increase in surface area. The identity of the membrane donor for this phase of mitosis remains unclear. Here we show by biochemical and imaging approaches that lysosomes undergo exocytosis during mitosis and that this requires the activity of phosphatidylinositol 4-kinase-III. Inhibition of lysosome exocytosis leads to mitotic failure in a significant proportion of cells suggesting that this facet of lysosome physiology is essential and represents a new regulatory mechanism in mitosis.
Introduction
The emergence of complex multicellular organisms including humans has rested upon the evolution of mechanisms by which single cells can duplicate themselves to build distinct organs and tissues. The process of mitosis in higher organisms is responsible for normal growth, development, aging and repair of most body structures and defects during this event can lead to disease states including cancer [1] . Understanding how mitosis is controlled is therefore fundamental to tackling a number of prevalent human developmental disorders and diseases.
It has long been known that mitosis involves dramatic alterations in cellular morphology and, particularly for adherent cell types, there is a weakening in attachment to the extracellular matrix on entry in to mitosis. This is accompanied by a significant reduction in plasma membrane (PM) surface area that manifests as cell rounding. These morphological changes appear intimately linked to activation of specific cell signalling pathways and cytoskeletal rearrangements occurring within the cytoplasm [2] . It was originally speculated that changes in cell volume and surface area could be achieved through folding and unfolding of the PM perhaps into villus like protrusions/invaginations and some cell types may employ this strategy [3, 4] . Intuitively it was speculated that an alternative mechanism for dynamic adjustment of PM surface area during mitosis could occur through the processes of endo-and exocytosis [4] . The first studies examining vesicular trafficking during mitosis identified endocytic compartments as potential sources of membrane for surface area expansion late in mitosis [5] while later work identified Golgi-derived vesicles as possible mediators of this phenomenon [6] .
Lysosomes are remarkably versatile intracellular organelles that perform numerous essential functions within cells [7] . They are master regulators of cellular metabolism, contribute to catabolism of cellular debris, including foreign pathogens, and are central to macro-autophagy [8] . In addition lysosomes are important calcium (Ca 2+ ) signalling platforms [9] and can facilitate repair of mechanical damage to the PM in most cell types [10] . This latter function of lysosomes depends upon their ability to undergo Ca 2+ -dependent exocytosis at the PM and a combination of lysosomal membrane material and soluble lysosomal hydrolases appear important in the process of wound healing [11] . More recently it has been proposed that excessive lysosomal exocytosis may in-part be responsible for the enhanced invasiveness of cancer cells [12, 13] . In work examining the role of a small Ca 2+ binding protein, CaBP7 and phosphatidylinositol 4-kinaseIII (PI4K) our laboratory uncovered a potentially unique role for lysosomes during mitosis in mammalian cells [14] . We characterised a highly organised and temporally coordinated clustering of lysosomes to the site of PM constriction in mitotic cells.
Inhibition of this clustering, through a PI4K-dependent mechanism, was accompanied by a significant increase in mitosis failure. Taken together these observations indicated that the spatial distribution of lysosomes had an important functional impact on mitosis progression. However, the exact role of lysosomes during mammalian cell division remains unclear. In the present study, with the knowledge that mitosis requires membrane remodelling and that an organelle(s) with the ability to undergo exocytosis could be important for PM expansion we have examined whether lysosomes undergo exocytosis during mitosis. Using a number of mammalian cell lines we show, using biochemical assays that track the release of soluble lysosomal content into the extracellular space, that there is an increase in lysosome exocytosis as cells undergo mitosis. These data were confirmed in Total Internal Reflection Fluorescence Microscopy (TIRFM) imaging studies where we monitored coordinated lysosome (organelles identified based on their ability to accumulate acidotropic dye but which were negative for mannose-6-phosphate receptor) trafficking and fusion events at the site of PM constriction.
Pharmacological inhibitors targeting the exocytic machinery or PI4K directly induced significant mitosis failure suggesting that PI4K-dependent lysosome exocytosis is functionally relevant for normal mitosis completion. We speculate that this behaviour of lysosomes could represent a new way to target rapidly proliferating cells to induce mitotic arrest.
Results

Lysosomal protein expression and surface appearance is upregulated in mitotic cells which exhibit a corresponding increase in lysosomal exocytosis.
We first examined if there were discernible differences in lysosomal protein expression and cellular distribution between asynchronous and chemically synchronised (thymidinenocodazole) cells ( Fig. 1A) . Surface proteins were labelled with a cell-impermeant biotinylated cross-linking reagent (Sulfo-NHS-SS-biotin), streptavidin affinity-purified from detergent extracted lysates and analysed by Western blotting for the lysosomal membrane protein LAMP-1 ( Fig. 1A ). Densitometry analysis of this data highlighted that intracellular LAMP-1 protein levels in mitotic cells increase 6.7-fold compared to levels in asynchronous cells.
(Tubulin loading control normalised, Fig. 1A ). In mitotic cells, surface LAMP-1 represented 8% of the total LAMP-1 signal (surface + cytosol) in comparison to 0.28% in asynchronous cells.
As a complimentary method to assess lysosomal protein at the PM we used surface immunofluorescence. Due to the difficulty of finding reliable antibodies directed towards luminal epitopes of lysosomal proteins, we developed LysopHluorin-mCherry (LpH-mCh, Fig. extended view 1A), an mCherry tagged, lysosomally targeted construct derived from the previously described Lyso-pHoenix [15] . LpH-mCh contains the CD63 lysosome targeting information followed by pHluorin (a pH sensitive ecliptic GFP variant quenched at acidic pH) and mCherry (a pH insensitive red fluorophore, pKa ~4.5) such that both tags are located within the lysosome lumen. LpH-mCh targets extensively to structures positive for the acidotropic dye Lysotracker® but largely negative for mannose-6-phosphate receptor ( Fig. extended view 1B and C) indicating that LpH-mCh is a lysosome-specific pH sensor. In cells expressing LpH-mCh, if a lysosome were to exocytose at the PM then the pHluorin and mCherry tags would become accessible at the cell surface to specific antibodies. We used mCherry fluorescence to determine LpH-mCh localisation throughout the cell and anti-RFP antibody for staining of non-permeabilised cells to detect surface-accessible mCherry protein ( Fig. 1B) . We normalised the surface LpH-mCh signal to total cellular LpH-mCh signal (PM + intracellular) and observed a statistically significant increase in surface LpH-mCh signal in mitotic cells (Fig. 1C ), consistent with our surface biotinylation data ( Fig. 1A) .
Having biochemical and imaging-based evidence that lysosomal membrane protein abundance at the PM apparently increased in mitotic cells we next wanted to test if this was due to lysosome exocytosis and not biosynthetic trafficking of newly synthesised LAMP-1 to lysosomes. The latter interpretation would be unusual since the Golgi apparatus fragments early during mitosis [16] precluding synthesis of new secretory pathway proteins and therefore would require a novel mechanistic explanation. We measured lysosome exocytosis directly using a previously characterised Lucifer Yellow (LY) uptake and secretion assay [10] . For these experiments we used BSC-1 cells (African green monkey kidney epithelial cells) since HeLa cells have previously been shown to exhibit relatively low levels of lysosome exocytosis [10] . LY exocytosis was determined at different time points: immediately (directly following release of the second thymidine block in mitotic cells (t = 0 hours)) or at 20 hours following the release (t = 20 hours), to permit synchronised cells to undergo a complete round of division.
Cells arrested in interphase were processed at precisely the same time points however they were maintained in the presence of thymidine for the entire experiment. Mitotis-and interphase-specific LY release was then calculated as fold changes between the t = 0 hour and t = 20 hour time points ( Fig. 1D ). Cells demonstrated a significant increase in exocytosis during mitosis, from a 0.99-fold increase in interphase to a 1.24 fold at mitosis ( Fig. 1D ). All data were corrected for cell death by examination of cell density in bright-field images ( Fig. extended view 2).
Lysosome exocytosis visualised by TIRFM in mitotic cells
Having acquired data indicating that lysosome exocytosis increases as cells progress through mitosis we examined this process at the level of individual exocytic events in live cells using TIRFM. In mitotic cells expressing LpH-mCh or loaded with Lysotracker® we observed a remarkable and highly dynamic clustering of lysosomes first to the site of PM constriction early in telophase and subsequently to either side of the intercellular bridge (as previously reported using standard confocal microscopy [14] ) ( Fig. 2A & B and Movies extended view 1, 2 and 3).
Employing diffusion analysis developed in [6] (see methods) to determine vesicle-PM fusion (exocytosis) we demonstrated that lysosomes underwent fusion events consistent with exocytosis at the PM in these cells ( Fig. 2C and D and Movies extended view 4 and 5). Over similar time courses in interphase cells we were unable to observe individual lysosome exocytosis events. Examination of TIRFM data showed that we were however able to detect numerous docking/undocking like events (movement of lysosomes towards and away from the PM) that were not accompanied by exocytosis in both mitotic and interphase cells ( Fig. 2E and movie extended view 6). In conjunction with diffusion analysis, we used the complimentary measurement of pHluorin de-quenching as a readout of lysosome exocytosis at the PM. To validate de-quenching as a diagnostic tool we first characterised exocytosis in cells at interphase, treated with 10 M ionomycin ( Fig. extended view 3 ). Upon fusion of lysosomes with the PM, the organelle lumen and the extracellular space become continuous, resulting in lysosomal alkalinisation and a marked increase in pHluorin fluorescence ( Fig. 2C and movies extended view 4 and 5). Collectively these data show that lysosomes are highly mobile at all stages of the cell cycle, cluster at either side of the intercellular bridge at telophase and exocytose during mitosis.
Inhibition of lysosome exocytosis with N-ethylmaleimide or PIK-93 induces mitotic failure
N-ethylmaleimide is a well-documented inhibitor of vesicular fusion events dependent upon the hexameric ATPase NSF [17, 18] . We treated LY loaded cells with 1mM NEM for 15 minutes and assessed the impact on lysosome exocytosis (Fig. 3A ). NEM treatment reduced lysosome exocytosis by approximately 40% and this correlated with a complete block on cell division monitored in live cell analysis of NEM treated mitotic cells ( Fig. 3B ). NEM is known to disrupt multiple NSF dependent trafficking events and as such is a non-specific inhibitor.
Based on previous data generated in our laboratory suggesting a role for PI4K in lysosome physiology and mitosis we tested the effect of the PI4K inhibitor PIK-93 [19] , on lysosome exocytosis ( Fig. 3C) . Although PIK-93 may not be completely specific for PI4K it is considerably more selective than NEM and was used at the published IC50 for PI4K (19 nM) which is significantly below the inhibitory concentration for other kinases. PIK-93 treatment of cells abolished Ca 2+ -dependent lysosome exocytosis of the soluble lysosomal hydrolase Nacetyl -D Glucosaminidase (NAG) [10] (Fig. 3C ) and significantly increased the proportion of polynucleated cells (Fig. 3F ). Having shown that inhibition of PI4K impairs exocytosis, we next examined the effect of PI4K overexpression on lysosomal fusion with the PM. Although detection of changes in lysosome exocytosis remained challenging in HeLa cells, overexpression of PI4K triggered a surprisingly significant increase in NAG release, further reinforcing the involvement of the enzyme in the exocytic process ( Fig. 3D) .
In order to test whether lysosomal hydrolases released during exocytosis are required mitosis completion we treated cells with the cathepsin inhibitor E64 ( Glycyl-L-phenylalanine 2-naphthylamide (GPN) is another reagent that has been used to interfere with lysosome function [20, 21] . It is a specific cathepsin C substrate which, once cleaved, is osmotically active within the lysosome lumen leading to excessive water accumulation and physical swelling/perforation of the organelle. Cells were treated overnight with GPN and then fixed for immunofluorescence analysis with an anti-tubulin antibody and DAPI staining. In a previous report we described an analysis of mitotic failure based on the appearance of cells with 2n copies of the nucleus or an increased frequency of cells connected by an intercellular bridge [14] . We used the same approach here to examine the effect of inhibiting lysosome activity with GPN. GPN treatment induced a significant increase in the proportion of bi-/tetra-nucleate cells and cells connected by a clearly identifiable intercellular bridge ( Fig. 3E and 3F ). Another pharmacological agent suggested to impair lysosome function, vacuolin-1, had no effect on mitosis ( Fig.3E and 3F) which is consistent with a previous report showing that this drug does not inhibit lysosome exocytosis [22] .
Discussion
Understanding the regulatory mechanisms that govern mitosis has huge potential impact for human health. The Spindle Assemble Checkpoint (SAC) is recognised as the most important regulatory mechanism that operates during mitosis [23, 24] . SAC is a valid anti-cancer target and a number of currently employed chemotherapeutic agents work by stabilising or destabilising the microtubule network (MT) to activate this checkpoint and stall cells undergoing division [1, 25] . Blocking mitosis in this way has the immediate effect of halting cell proliferation but has an added advantage in that such cells can enter mitotic cell death ultimately destroying transformed cells. Drugs such as Taxol (MT stabiliser) and the vinca alkaloids (MT destabilsers) have been employed clinically for many decades however they have potential off-target effects on normal cells and therefore new generation anti-mitosis agents will ideally exhibit greater cancer cell selectivity [1] . One way in which specificity can be enhanced is to identify new regulatory inputs required for successful mitosis completion.
Roles for phosphoinositide metabolism [26, 27] , calcium signalling [28] and vesicular membrane trafficking [5, 6] during mitosis have been reported although are significantly less well understood. Control of membrane remodelling during mitosis is accepted as integral for normal cell division and manipulations that prevent cell-rounding place a block on mitosis [5] .
The underlying cell biology mediating membrane contraction and expansion have been investigated in previous studies and it appears that multiple membrane trafficking pathways could be involved [5, 6] . These reports provide unique insights into organelle exocytosis during mitosis but they do not prove unequivocally that either Golgi vesicles or endosomes are essential for normal mitosis.
In a previous study, we reported a distinct redistribution of lysosomes in mitotic HeLa cells which appeared to have functional relevance for mitosis completion [14] . Exocytosis of lysosome related organelles is important in a number of professional secretory cell types, particularly those of the immune system [29] . In pioneering studies the work of the Andrews laboratory described a more general feature of standard lysosomes, present in almost all cell types, to undergo Ca 2+ -dependent exocytosis in response to PM damage [10, 30] . These observations uncovered a previously unknown and unexpected property of lysosomes, which has since been implicated in cancer cell migration and drug resistance [12, 13, 31] . It is clear that lysosomes serve multiple important functions in cells with increasing attention being paid to their influence on cancer cell behaviour.
In this study we describe how a known lysosome function acts in a hitherto unknown but essential area of mammalian cell biology. We have characterised lysosome exocytosis in various mammalian cell types undergoing mitosis and show that disruption of this function impairs normal mitosis completion. Our data suggest that lysosomes serve a general function during mitosis that requires their exocytosis at the cell PM. One interpretation of our results is that, under normal conditions, lysosome exocytosis is linked to the PM remodelling, particularly membrane expansion, that occurs during telophase in mitotic cells. This is the first study to combine biochemical analyses of organelle exocytosis with high resolution imaging to describe how lysosomes might contribute additional membrane during mitosis. Lysosome exocytosis as a general mechanism for PM wound repair in various cell types was characterised over twenty years ago [10] . The prevailing model posited that lysosomal membrane was incorporated into the lesion to restore PM integrity [30] . This view has been refined by more recent reports showing that soluble lysosomal hydrolases released upon lysosome exocytosis are key extracellular factors in PM wound repair [11, 32] . Acid sphingomyelinase [32] and the cysteine proteases cathepsin B and L [11] have been shown to be required for PM repair. We examined whether the same machinery that is involved in PM wound repair also operates during mitosis by treating cells with the cathepsin inhibitor E64 and assessing the impact on mitosis completion. Since E64 treatment did not inhibit mitosis this suggests that the exocytosis of lysosomes during mitosis serves a mechanistically distinct function from that which operates during PM wound repair which we interpret as membrane donation.
Lysosome exocytosis during mitosis is also unique in that it is a PI4K dependent process.
PI4K is responsible for generating phosphatidylinositol-4-phosphate, a fusogenic lipid, and has a well-documented activity in the biogenesis of anterograde transport vesicles at the Trans-Golgi Network [33] . A previous study characterised a biochemically distinct pool of PI4K on lysosomes [34] and our observations indicate that a potential function of the kinase on these organelles is to prime them for exocytosis at the PM. The data presented here are consistent with our previous work where we demonstrated that expression of CaBP7, a PI4K inhibitor, disrupts lysosome clustering and inhibits mitosis [14] . Interestingly, the effect of PIK-93 observed in this study was larger in NRK cells compared with HeLa cells which may reflect a heightened sensitivity to the drug of cells exhibiting higher levels of Ca 2+ -stimulated lysosome exocytosis. This suggests that PI4K has a key role in lysosome function during mitosis in mammalian cells and that it is required for Ca 2+ -dependent exocytosis. The role of PI4K in lysosome exocytosis may not be restricted exclusively to mitosis and could be required for exocytosis of these organelles more generally, including during PM wound repair, however, to date, this possibility has yet to be investigated.
Collectively, our data highlight a novel role for PI4K in lysosome exocytosis, a process that represents a potentially new regulatory input controlling mitosis progression, and which may offer an additional means to enhance the specificity in targeting rapidly proliferating cells.
Material and methods
Cell culture
HeLa, HEK293T and NRK-49F cells were maintained in HN media (DMEM supplemented with 
Cell Synchronisation
Cells were first arrested at interphase with 2 mM thymidine for a minimum of 20 hours, released from their block with 25 µM deoxycytidine for 3 to 6 hours and blocked again by 2 mM thymidine or 35 ng/ml nocodazole (pro-metaphase block) for 12 to 24 hours. Subsequently cells were either maintained in their block or released with 25 µM deoxycytidine. Prior to all releases, cells were washed 5 times with 10 ml fresh culture medium.
Biotinylation of cell surface proteins
Synchronous (thymidine-nocodazole treated) and asynchronous HeLa cells were grown to full confluence on 10 cm circular cell culture dishes. Synchronised cells were washed five times with 10 ml HN media to release them from the block and incubated for 1 hr at 37 o C in a tissue culture incubator. The culture media was removed from both populations and cells washed Membranes were then washed three times with PBST and twice with PBS, before addition of equal volumes of enhanced chemiluminescence reagents (Clarity, Biorad). Blots were subsequently developed and imaged using a ChemiDoc-XRS system (BioRad). Densitometry of gel images was performed with ImageJ. 
SDS-PAGE and Western blotting
Immunofluorescence for cytokinesis and polynucleate cell count
Surface staining
Cells were kept on ice at all times and all reagents were maintained at 4°C throughout the whole procedure to inhibit the endocytic process. 
Lucifer Yellow (LY) assay
Cells were incubated in culture medium supplemented with 1 mg/ml LY carbohydrazide (CH) dipotassium salt (Santa Cruz) for 4 hours or overnight, at 37°C, 95% (v/v) air/5% (v/v) CO2, washed 3 times in PBS and chased in fresh culture medium for a minimum of 2 hours at 37°C, 5% (v/v) CO2. Cells were subsequently lysed and the incubation buffer collected as described in Cell lysis and media collection for biochemical assays. LY fluorescence was measured in the incubation buffer/cell lysate with excitation at 428 nm/emission at 536 nm wavelengths using a Jasco FP-6300 spectrofluorimeter.
Cell lysis and media collection for biochemical assays
Cell incubation media were collected and stored on ice. All reagents and cells were maintained at 4°C throughout the lysis process. Cells were washed twice in PBS and incubated on ice on a rocking platform with RIPA buffer (ThermoScientifc TM ) for 5 min. They were subsequently scraped from culture dishes and an equal volume of ice cold PBS added. Cellular debris were pelleted by centrifugation for 15 min at 13,000 rpm and the clarified lysates transferred to fresh tubes.
N-Acetyl-β-D-Glucosaminidase (NAG) assay
Cells were subsequently lysed and the incubation buffer collected as described in Slidebook and Zen software suites were used for image acquisition. Images were processed and analysed using Fiji.
Statistical analysis
Unless stated otherwise experiments were performed at least in triplicate (N = 3) and results are expressed as mean ± S.E.M. When applicable, the number of cells (n) is stated in the figure legends. All statistical analyses were performed on GraphPad Prism 6 software.
Students' unpaired t-tests was used for statistical comparison between groups, as indicated and p values in the figures are represented by stars (*p < 0.05, **p < 0.01 and ***p < 0.001). 
Figure legends
